摘要
比较了淋巴因子IL-2、IL-4和IL-7在体外诱导健康人外周血淋巴因子激活的杀伤 (LAK)细胞活性的效应。结果表明,IL-7可单独,亦可与IL-2、IL-4协同诱导LAK细胞,而且IL-7 诱导LAK细胞的效应不被抗IL-2、抗IL-4所抑制。IL-7单独诱导的LAK细胞活性高峰迟于IL- 2或IL-4所诱导的活性高峰,且与增殖反应曲线一致。抗CD8抗体明显抑制IL-7诱导LAK细胞 的效应,而IL-7诱导LAK细胞的效应不能被抗NKH-1所抑制。提示:IL-7 激活LAK细胞的效应 机制不依赖IL-2和IL-4,并很可能成为肿瘤过继治疗中的重要淋巴因子。
Had investigated and compared the effect of IL-2, IL-4 and IL-7 on the generation of lymphokine-activated killer (LAK) cell activity in human peripheral blood mononuclear cells of healthy individuals. The data demonstrated that the kinetics of IL-7 induced LAK activity peaked at day 8 while that of IL-2 or IL-4 induced LAK activity peaked at day 4. In lymphokine activated proliferative response a similar pattern of responsiveness was obtained. A synergy was found and maintained over longer periods of time when IL-7 was added together with IL-2 or IL-4. However,when we studied the effects of anti-IL-2 or anti-IL-4 on IL-7 induced LAK activity,we found that neither IL-2 nor IL-4 might influence the generation of LAK cells mediated by IL-7. The function analysis of CD8, CD4 and NKH-1 on lymphokine mediated LAK activiy indicated that LAK activity induced by IL-7 was completely eliminated by treatment with anti-CD8,but not by anti-CD4 or anti-NKH-1. These results suggest that IL-7 may act independently of IL-2 and IL-4 and is more effective on the induction of human LAK cells, either alone or in combination with IL-2 or IL-4, could be very important for adoptive immunotherapy.
出处
《中国免疫学杂志》
CAS
CSCD
北大核心
1996年第1期6-9,共4页
Chinese Journal of Immunology